An Enhanced Metabolization Protocol for In Vitro Genotoxicity Assessment of N‐Nitrosamines in Mammalian Cells
Environmental and Molecular Mutagenesis · 2025
DOI: 10.1002/em.70009 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Environmental and Molecular Mutagenesis, 2025. Verfasst von M E Geijer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Toxys B.V., Oegstgeest, the Netherlands. Hauptthemen laut MEDLINE: Nitrosamines, Mutagens. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
N‐Nitrosamines (NAs) are probable human carcinogens and were detected as impurities in pharmaceuticals, which led to a concern for human health. NAs require metabolic activation before they become mutagenic, and not all NAs are mutagenic since their reactivity is related to their structure. While some NAs are potent mutagens in vivo, in vitro metabolization with exogenous S9 liver extract is generally less efficient. While an enhanced bacterial mutagenicity protocol was recently developed, which uses increased concentrations of S9 liver extracts, there presently is not an improved metabolization protocol suitable for mammalian cell genotoxicity assays. Therefore, we optimized a hamster S9 liver extract‐based protocol for in vitro NA metabolization and assessed the genotoxic potential of various NAs using ToxTracker. With this enhanced metabolization protocol (EMP), the genotoxic potency of N‐nitrosodimethylamine (NDMA) increased approximately 200‐fold compared with the standard S9 liver extract‐based exposure protocol in ToxTracker. The EMP was further validated with seven additional mutagenic NAs to which humans are commonly exposed: N‐nitrosodiethylamine (NDEA), N‐nitrosodiethanolamine (NDELA), N‐nitrosodibutylamine (NDBA), N‐nitrosofluoxetine (NF), 1‐nitrosopyrrolidine (NPYR), N‐nitrosomorpholine (NMOR), and 1‐cyclopentyl‐4‐nitrosopiperazine (CPNP), and two non‐mutagenic NAs: N‐nitrosobupropion (NBuPRO) and N‐nitrosoproline (NPRO). Genotoxicity could be confirmed for six NAs using the EMP, demonstrating that mammalian cells and the new approach methodology (NAM) ToxTracker may have potential when investigating NA‐related genotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Toxys B.V., Oegstgeest, the Netherlands.
ORCID-Profile: M E Geijer, I Brandsma, G Hendriks
Zitieren
APA
Geijer, M. E., Gernaat, A. M., Moelijker, N., Brandsma, I., & Hendriks, G. (2025). An Enhanced Metabolization Protocol for In Vitro Genotoxicity Assessment of N‐Nitrosamines in Mammalian Cells. Environmental and Molecular Mutagenesis. https://doi.org/10.1002/em.70009
Vancouver
Geijer ME, Gernaat AM, Moelijker N, Brandsma I, Hendriks G. An Enhanced Metabolization Protocol for In Vitro Genotoxicity Assessment of N‐Nitrosamines in Mammalian Cells. Environmental and Molecular Mutagenesis. 2025. doi:10.1002/em.70009
BibTeX
@article{Geijer2025,
author = {Geijer, M E and Gernaat, A M and Moelijker, N and Brandsma, I and Hendriks, G},
title = {An Enhanced Metabolization Protocol for In Vitro Genotoxicity Assessment of N‐Nitrosamines in Mammalian Cells},
journal = {Environmental and Molecular Mutagenesis},
year = {2025},
doi = {10.1002/em.70009}
}
EUVIMED